B.J. Ledwith
Department of Safety Assessment
Merck Research Laboratories
Merck & Co.
Inc., West Point
USA
Name/email consistency: high
- Tumorigenicity assessments of Per.C6 cells and of an Ad5-vectored HIV-1 vaccine produced on this continuous cell line. Ledwith, B.J., Lanning, C.L., Gumprecht, L.A., Anderson, C.A., Coleman, J.B., Gatto, N.T., Balasubramanian, G., Farris, G.M., Kemp, R.K., Harper, L.B., Barnum, A.B., Pacchione, S.J., Mauer, K.L., Troilo, P.F., Brown, E.R., Wolf, J.J., Lebronl, J.A., Lewis, J.A., Nichols, W.W. Dev. Biol. (Basel) (2006)
- Plasmid DNA vaccines: investigation of integration into host cellular DNA following intramuscular injection in mice. Ledwith, B.J., Manam, S., Troilo, P.J., Barnum, A.B., Pauley, C.J., Griffiths, T.G., Harper, L.B., Beare, C.M., Bagdon, W.J., Nichols, W.W. Intervirology (2000)
- Induction of cyclooxygenase-2 expression by peroxisome proliferators and non-tetradecanoylphorbol 12,13-myristate-type tumor promoters in immortalized mouse liver cells. Ledwith, B.J., Pauley, C.J., Wagner, L.K., Rokos, C.L., Alberts, D.W., Manam, S. J. Biol. Chem. (1997)